Ultragenyx Pharmaceutical's Series A Round

Ultragenyx Pharmaceutical raised a round of funding on June 20, 2011.

Ultragenyx Pharmaceutical is a developmental stage biotechnology company committed to bringing life-enhancing therapeutics for patients with rare and ultra-rare genetic diseases, also known as orphan …

Articles about Ultragenyx Pharmaceutical's Series A Round: